USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ

Yuan, Putao; Feng, Zhenhua; Huang, Hai; Wang, Gangliang; Chen, Zhijun; Xu, Guang; Xie, Ziang; Jie, Zhiwei; Zhao, Xiangde; Ma, Qingliang; Wang, Shiyu; Shen, Yang; Huang, Yizhen; Han, Ying; Ye, Huali; Wang, Jiying; Shi, Peihua; Sun, Xuewu

doi:10.7150/ijbs.65428

Theranostics

International Journal of Medical Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

open access Global reach, higher impact

Full Text | PDF

Int J Biol Sci 2022; 18(8):3122-3136. doi:10.7150/ijbs.65428 This issue Cite

Research Paper

USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ

Putao Yuan^1,2,3*, Zhenhua Feng^1,2*, Hai Huang^1,2,4*, Gangliang Wang^1,2*, Zhijun Chen^1,2,3, Guang Xu^1,2, Ziang Xie^1,2, Zhiwei Jie^1,2, Xiangde Zhao^1,2, Qingliang Ma^1,2, Shiyu Wang^1,2, Yang Shen^1,2, Yizhen Huang^1,2, Ying Han^1,2, Huali Ye^1,2, Jiying Wang^1,2, Peihua Shi^1,2,3✉, Xuewu Sun^1,2,3✉

1. Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine.
2. Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province.
3. Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
4. 903RD Hospital of Pla, Hangzhou, China.
*These authors contributed equally to this work.

Citation:

Yuan P, Feng Z, Huang H, Wang G, Chen Z, Xu G, Xie Z, Jie Z, Zhao X, Ma Q, Wang S, Shen Y, Huang Y, Han Y, Ye H, Wang J, Shi P, Sun X. USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ. Int J Biol Sci 2022; 18(8):3122-3136. doi:10.7150/ijbs.65428. https://www.ijbs.com/v18p3122.htm

Other styles

Abstract

Mutations and altered expression of deubiquitinating enzymes (DUBs) profoundly influence tumor progression. Ubiquitin-specific protease 1 (USP1) is a well-characterized human DUB reportedly overexpressed in and associated with maintaining the mesenchymal stem cell status of osteosarcoma (OS); however, the potential mechanisms of USP1 in OS remain poorly understood. In this study, we identified that USP1 directly interacts with Transcriptional Co-Activator With PDZ-Binding Motif (TAZ) in OS cell lines, and with mechanistic analysis indicating that the anti-OS effects of USP1 inhibition could be partially attributed to TAZ instability, with its reduced nuclear accumulation responsible for a subsequent decrease in the expression of downstream genes associated with the Hippo signaling pathway. Moreover, pharmacological inhibition USP1 by ML323 presented the similar effects on Hippo signaling pathway and suppressed OS growth and metastasis both in vitro and in vivo. Taken together, our results revealed a novel molecular mechanism underlying the function of USP1 in OS and a potential role of ML323 as a therapeutic strategy for the clinical treatment of OS.

Keywords: Osteosarcoma, USP1, TAZ, Hippo, Ubiquitin, ML323

Citation styles

APA

Yuan, P., Feng, Z., Huang, H., Wang, G., Chen, Z., Xu, G., Xie, Z., Jie, Z., Zhao, X., Ma, Q., Wang, S., Shen, Y., Huang, Y., Han, Y., Ye, H., Wang, J., Shi, P., Sun, X. (2022). USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ. International Journal of Biological Sciences, 18(8), 3122-3136. https://doi.org/10.7150/ijbs.65428.

ACS

Yuan, P.; Feng, Z.; Huang, H.; Wang, G.; Chen, Z.; Xu, G.; Xie, Z.; Jie, Z.; Zhao, X.; Ma, Q.; Wang, S.; Shen, Y.; Huang, Y.; Han, Y.; Ye, H.; Wang, J.; Shi, P.; Sun, X. USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ. Int. J. Biol. Sci. 2022, 18 (8), 3122-3136. DOI: 10.7150/ijbs.65428.

NLM

CSE

Yuan P, Feng Z, Huang H, Wang G, Chen Z, Xu G, Xie Z, Jie Z, Zhao X, Ma Q, Wang S, Shen Y, Huang Y, Han Y, Ye H, Wang J, Shi P, Sun X. 2022. USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ. Int J Biol Sci. 18(8):3122-3136.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.